@article{7fcbbaf631e344879d9b8526c84463c0,
title = "In a Pinch: Cefiderocol for CRAB Infections",
abstract = "Carbapenem-resistant Acinetobacter baumannii (CRAB) can cause significant infections with limited treatment options available. Falcone et al. (https://doi.org/ 10.1128/aac.02142-21) describe a single-center retrospective study comparing clinical outcomes among patients with CRAB infections treated with cefiderocol-containing versus colistin-containing regimens. Patients who received cefiderocol-containing regimens had lower 30-day mortality, though there are several limitations raised here, which make interpretation and applicability difficult.",
keywords = "Acinetobacter, CRAB, cefiderocol",
author = "Karaba, {Sara M.} and Hirsch, {Elizabeth B.} and Heil, {Emily L.}",
note = "Funding Information: Copyright {\textcopyright} 2022 American Society for Microbiology. All Rights Reserved. Address correspondence to Sara M. Karaba,
[email protected]. For the article discussed, see https://doi.org/ 10.1128/AAC.02142-21. The authors declare a conflict of interest. E.B.H. has received research funding from Merck and advisory board honoraria from Melinta, MeMed, and Merck. E.L.H. consults for Wolters/ Kluwer (LexiComp). The views expressed in this article do not necessarily reflect the views of the journal or of ASM. Published 11 April 2022 Publisher Copyright: {\textcopyright} 2022 American Society for Microbiology.",
year = "2022",
month = may,
doi = "10.1128/aac.00065-22",
language = "English (US)",
volume = "66",
journal = "Antimicrobial agents and chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "5",
}